Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trialLi Zhang, Mengzhao Wang, Shujun Yang et al.|The Lancet Oncology|2012Cited by 228
Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non–Small-Cell Lung Cancer (INFORM; C-TONG 0804)Hongyun Zhao, Li Zhang, Yun Fan et al.|Journal of Thoracic Oncology|2015Cited by 44
Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancerLiang Huang, Zhimin Shao, Xiaojia Wang et al.|Cancer Chemotherapy and Pharmacology|2019Cited by 10